Please Wait

Applying Filters...

Looking for Cholini salicylas [INN-Latin]? Find Controlled & Modified Release used in Cholini salicylas [INN-Latin] to address drug delivery challenges on PharmaCompass.

Cholini salicylas [INN-Latin]

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

8 API Suppliers, 1 USDMF, 2 EU WC, 1 NDC API, 7 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

1 FDF Dossiers, 1 Listed Dossiers

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 4 Rochem International Inc, 2 SPI Pharma, 1 DKSH, 1 Pharm-RX Chemical, 2 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 7 Actylis, 1 BASF, 1 Bioplus Life Sciences, 1 CD Formulation, 1 Finar, 2 Pluviaendo, 18 Roquette, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Valens Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

14 Film Formers & Plasticizers, 13 Taste Masking, 9 Fillers, Diluents & Binders, 7 Coating Systems & Additives, 7 Thickeners and Stabilizers, 7 Parenteral, 5 Topical, 3 Chewable & Orodispersible Aids, 2 Solubilizers, 2 Controlled & Modified Release, 1 Co-Processed Excipients, 1 Direct Compression, 1 Soft Gelatin, 1 Emulsifying Agents

MARKET PLACE

5 APIs, 1 Intermediates

$ Xls

Filters

Cholini Salicylas [INN-Latin]

Filters

FILTER :

filter Company Reset all filters

4 All

01 4Actylis

filter Capability Reset all filters

filter Country Reset all filters

01

Actylis

SODIUM CITRATE DIHYDRATE MULTI-COMPENDIAL

AGGSpend

Not Confirmed

02

Actylis

SODIUM CITRATE DIHYDRATE USP-NF

AGGSpend

Not Confirmed